Afya Limited (AFYA)

USD 14.58

(-3.64%)

Market Cap (In USD)

1.31 Billion

Revenue (In USD)

2.87 Billion

Net Income (In USD)

386.32 Million

Avg. Volume

139.88 Thousand

Currency
USD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
14.52-22.48
PE
-
EPS
-
Beta Value
0.917
ISIN
KYG011251066
CUSIP
G01125106
CIK
1771007
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Education & Training Services
CEO
Mr. Virgilio Deloy Capobianco Gibbon
Employee Count
-
Website
https://www.afya.com.br
Ipo Date
2019-07-19
Details
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.